Launch of Clinical Research Development Ireland

CRDI Farmleigh Launch

Minister for Health Mr Simon Harris TD (centre) with Dr Pat O’Mahony, Chief Executive of CRDI, and Mr Thomas Lynch, Chairman of CRDI at Farmleigh at the launch.

On Monday 2 October 2017, Minister for Health Simon Harris TD  unveiled a new name and brand identity for a leading national academic research body that aims to increase Ireland’s position as a centre of excellence and attract clinical and translational research projects that can ultimately improve and enhance public health.

Clinical Research Development Ireland (CRDI) is the new name for Molecular Medicine Ireland (MMI), a not for profit partnership established by NUI Galway, Royal College of Surgeons in Ireland, Trinity College Dublin, University College Cork and University College Dublin, their associated academic hospitals and clinical research facilities.

CRDI’s ambitious Strategic Plan 2017 – 2021 was also presented at the event, which was held in the stately surroundings of Farmleigh House, and attended by key representatives from the Irish and international academic, public and private sectors.

CRDI acts as a central contact point for the development of collaborative research with academic and industry partners from Ireland and abroad. It does this by helping to develop, co-ordinate and facilitate research programmes and networks in a wide range of therapeutic areas in both medicines and medical devices.

Since it was first established in 2002, it has provided training, including structured PhD programmes and Good Clinical Practice (GCP) courses, to over 4,600 Irish researchers, it has jointly facilitated almost 200 clinical research  studies and has helped to position Ireland as a prime location for the conduct of clinical and translational research. CRDI works with funding agencies that include the Health Research Board, Enterprise Ireland, Science Foundation Ireland, Wellcome Trust and the Irish Cancer Society.

Presentation & Brochure downloads